https://www.selleckchem.com/pr....oducts/conteltinib-c
We use the Cochrane Risk of a bias assessment tool to evaluate methodological qualities. Data synthesis will be completed by RevMan 5.3.0. We will show the results of this study in a peer-reviewed journal. This meta-analysis will provide reliable evidence for moxibustion treatment of DQD. INPLASY2020100111. INPLASY2020100111. Ulcerative colitis (UC) is an inflammatory bowel disease characterized by a relapsing and remitting course, and the curative medical therapy of UC is not yet available with its precise etiology unknown.
Curtir
Comentario
Compartilhar
